Our work in vaccines focuses on making certain diseases a thing of the past.
Vaccines are one of the greatest public health success stories in history
Without vaccines, the world would have lost more sons, daughters, moms and grandpas – more future teachers, builders, doctors and inventors – more people than an entire country the size of the Belgium.
Our work in vaccines
Experience in vaccines
We've been discovering, developing and delivering vaccines to help prevent disease around the world for over 100 years.
It is no secret that inventing and developing vaccines is complex, time intensive and carries no guarantees.
To keep pace with the ever-evolving disease landscape, we continue to research candidates to address significant unmet needs.
Collaboration and progress in vaccines
It takes active collaboration by our teams who partner with governments, academic researchers and non-government organizations around the world.
Our work in researching and producing vaccines is guided by science and fueled by human need.
There are many aspects of our work in vaccines
An optimal healthcare is a healthcare where the patient has fast and easy access to the best possible care. Organizing such an optimal healthcare system is a huge challenge. As an actor and partner, MSD Belgium wants to contribute in shaping the healthcare of the future.
Meet our leaders at MSD BeLux: Rietja Hart, Finance Lead
We are continuing a series of articles in which we would like to introduce you to our leaders at MSD BeLux, to get to know what drives them in their roles, what it’s like to lead at MSD BeLux, and what it’s like being part of a company with such a significant impact on the […]
Katrien De Vos appointed to Managing Director, MSD Belgium & Luxembourg
Katrien De Vos has taken the lead of MSD Belgium & Luxembourg since Monday, May 1. In her new role of Managing Director, she takes over from An Cloet, External Affairs Director at MSD Belgium, who held the position ad interim for the past 6 months. Prior to joining MSD, Katrien De Vos held various […]
Meet our leaders at MSD BeLux: Dr. Laurent Viérin, Country Medical Director
We are starting a series of articles in which we would like to introduce you to our leaders at MSD BeLux, to get to know what drives them in their roles, what it’s like to lead at MSD BeLux, and what it’s like being part of a company with such a significant impact on the […]
Together against pneumococcal diseases
What are the numbers onhospitalisation and deaths? For adults above the age of 50, the chance at hospitalisation is lower in comparison to adults above the age of 65. Yet, pneumococcal diseases cause 5800 adults above the age of 50 to be hospitalised every year.2 As people get older, the chance of developing severe symptoms […]
Our commitment to patients is unwavering
As long as there are still patients in hospitals, doctors desperate to add years to the lives of their patients, and a world where treatments aren’t accessible to all, we will be here: fighting with all we have to deliver more, sooner.
For over 100 years, we have been developing well-tolerated and effective vaccines that protect the lives of millions of people. Our vaccines help to make highly infectious diseases, such as rubella, a rare disease today and to prevent certain HPV-related diseases. Our portfolio currently includes vaccines for children, adolescents and adults.
A - H
Hepatitis B Virus
Hepatitis B Virus
I - O
Measles - Mumps - Rubella Virus
P - Z
Pneumococcal Polysaccharide, 23-Valent
Measles - Mumps - Rubella - Varicella Virus
Hepatitis A Virus
Hepatitis A Virus
Varicella Zoster Virus